Surprisingly, compared with control group, the proportion of SP cells in tumor samples from mice treated with hIMB1636-LDP-AE was significantly reduced (0.59 vs.1.29, Fig. 8e), which further indicated that it owned the ability to kill cancer stem cells in vivo. The gene discussed is CPQ; the disease is cancer.